Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA

OBJECTIVES: To correlate immune responses following a two-dose regimen of mRNA anti-SARS-CoV-2 vaccines in patients with rheumatoid arthritis (RA) to the development of a potent neutralising antiviral activity. METHODS: The RECOVER study was a prospective, monocentric study including patients with R...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmiedeberg, Kristin, Abela, Irene A, Pikor, Natalia Barbara, Vuilleumier, Nicolas, Schwarzmueller, Magdalena, Epp, Selina, Pagano, Sabrina, Grabherr, Sarah, Patterson, Angelica Brooke, Nussberger, Madalina, Trkola, Alexandra, Ludewig, Burkhard, von Kempis, Johannes, Rubbert-Roth, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615173/
https://www.ncbi.nlm.nih.gov/pubmed/36288822
http://dx.doi.org/10.1136/rmdopen-2022-002575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615173/
https://www.ncbi.nlm.nih.gov/pubmed/36288822
http://dx.doi.org/10.1136/rmdopen-2022-002575

Ejemplares similares